4.6 Article

Targeting the elevated IFN-gamma in vitiligo patients by human anti- IFN-gamma monoclonal antibody hampers direct cytotoxicity in melanocyte

Related references

Note: Only part of the references are listed.
Article Immunology

Skin Interstitial Fluid and Plasma Multiplex Cytokine Analysis Reveals IFN-γ Signatures and Granzyme B as Useful Biomarker for Activity, Severity and Prognosis Assessment in Vitiligo

Chau Yee Ng et al.

Summary: This study aims to evaluate the cytokine expression profiles in the skin and plasma and the utility of the biomarker panel in assessing disease activity, severity, and prognosis in patients with vitiligo. The results showed that IFN-gamma, CXCL9, CXCL10, and GzmB are highly expressed in vitiligo patients' lesion skin and plasma and may serve as biomarkers for the clinical activity, severity, and prognosis prediction in vitiligo patients. Among all, IFN-gamma exerts the highest predictive value in disease activity and treatment response, supporting the critical role of IFN-gamma in the pathogenesis of vitiligo.

FRONTIERS IN IMMUNOLOGY (2022)

Article Biochemistry & Molecular Biology

Synergism of TNF-α and IFN-γ Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes

Rajendra Karki et al.

Summary: The combination of TNF-alpha and IFN-gamma induces inflammatory cell death characterized by PANoptosis, which can be inhibited to protect mice from the pathological effects and death caused by COVID-19. Blocking the cytokine-mediated inflammatory cell death signaling pathway may benefit patients with COVID-19 or other infectious and autoinflammatory diseases by limiting tissue damage/inflammation.
Review Cell Biology

Ferroptosis: molecular mechanisms and health implications

Daolin Tang et al.

Summary: Cell death can be executed through different subroutines, such as ferroptosis which is an iron-dependent form of non-apoptotic cell death. Ferroptosis can occur through two major pathways, driven by redox imbalance and abnormal expression of redox-active enzymes. The process is precisely regulated at multiple levels, with the transcription factor NFE2L2 playing a central role in anti-ferroptotic defense.

CELL RESEARCH (2021)

Review Chemistry, Medicinal

Mechanisms of melanocyte death in vitiligo

Jianru Chen et al.

Summary: Vitiligo is an autoimmune depigment disease caused by the destruction of melanocytes due to various factors, including genetic susceptibility, oxidative stress, and immune dysfunction. Research suggests that most melanocyte deaths are a result of abnormal immune responses, including heightened innate immunity, skewed T helper cells, and cytotoxic T lymphocytes.

MEDICINAL RESEARCH REVIEWS (2021)

Review Oncology

The fate of melanocyte: Mechanisms of cell death in vitiligo

Xiuyi Wu et al.

Summary: Vitiligo is characterized by the loss of melanocytes, with apoptosis being the most studied cell death pathway, but conventional necrosis and autophagy may also play a role. New types of regulated cell death as well as anoikis are likely involved in the pathogenesis of vitiligo.

PIGMENT CELL & MELANOMA RESEARCH (2021)

Article Dermatology

Elevated serum level of interleukin-15 in vitiligo patients and its correlation with disease severity but not activity

Mona A. Atwa et al.

Summary: Background Vitiligo is a common acquired disorder of depigmentation. IL-15, a cytokine in the IL-2 family, plays a crucial role in autoimmune diseases but has been poorly investigated in patients with vitiligo. The study found that serum IL-15 levels were significantly higher in patients with vitiligo compared to healthy controls, and there was a positive correlation between IL-15 levels and vitiligo severity.

JOURNAL OF COSMETIC DERMATOLOGY (2021)

Review Rheumatology

Targeting interferon-γ in hyperinflammation: opportunities and challenges

Fabrizio De Benedetti et al.

Summary: Interferon-gamma (IFN gamma) plays a crucial role in immune responses and its overproduction is associated with hyperinflammation. Research has identified relevant biomarkers related to IFN gamma and shown promising results of IFN gamma-neutralizing agents in the treatment of specific diseases.

NATURE REVIEWS RHEUMATOLOGY (2021)

Article Cell Biology

scRNA-seq of human vitiligo reveals complex networks of subclinical immune activation and a role for CCR5 in Treg function

Kyle J. Gellatly et al.

Summary: The study revealed that cytokine signaling plays a critical role in the progression of vitiligo, while regulatory T cells also participate in inhibiting disease development. The CCL5-CCR5 signaling pathway acts as a chemokine circuit between effector CD8(+) T cells and Tregs.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Article Medicine, General & Internal

Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis

F. Locatelli et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Medicine, General & Internal

Ruxolitinib cream for treatment of vitiligo: a randomised, controlled, phase 2 trial

David Rosmarin et al.

LANCET (2020)

Article Multidisciplinary Sciences

CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy

Weimin Wang et al.

NATURE (2019)

Review Immunology

Cell death-mediated cytokine release and its therapeutic implications

David E. Place et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2019)

Article Allergy

Vitiligo: Mechanistic insights lead to novel treatments

Michael L. Frisoli et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)

Letter Dermatology

CXCL12 as a Predictor of Vitiligo Activity and Disease Progression

Vitali Alexeev

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2017)

Letter Dermatology

Alterations of CXCL12 in Serum of Patients with Vitiligo

Reinhart Speeckaert et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2017)

Article Dermatology

Suction blistering the lesional skin of vitiligo patients reveals useful biomarkers of disease activity

James P. Strassner et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2017)

Review Dermatology

JAK inhibitors in dermatology: The promise of a new drug class

William Damsky et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2017)

Review Immunology

Biomarkers of disease activity in vitiligo: A systematic review

R. Speeckaert et al.

AUTOIMMUNITY REVIEWS (2017)

Review Immunology

The role of IL-17 in vitiligo: A review

Rasnik K. Singh et al.

AUTOIMMUNITY REVIEWS (2016)

Review Dermatology

Vitiligo: How do oxidative stress-induced autoantigens trigger autoimmunity?

Heng Xie et al.

JOURNAL OF DERMATOLOGICAL SCIENCE (2016)

Article Dermatology

IFN-γ in vitiligo, is it the fuel or the fire?

J Harris

ACTA DERMATO-VENEREOLOGICA (2015)

Article Medicine, Research & Experimental

Role of oxidative stress in the pathogenesis of vitiligo with special emphasis on the antioxidant action of narrowband ultraviolet B phototherapy

Neslihan Karsli et al.

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2014)

Letter Oncology

Autopsy of a cell

L. J. Bendall et al.

LEUKEMIA (2014)

Article Multidisciplinary Sciences

Interferon-γ Induces Senescence in Normal Human Melanocytes

Suiquan Wang et al.

PLOS ONE (2014)

Article Multidisciplinary Sciences

IFN-γ signaling maintains skin pigmentation homeostasis through regulation of melanosome maturation

Vivek T. Natarajan et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)

Article Cell Biology

CXCL10 Is Critical for the Progression and Maintenance of Depigmentation in a Mouse Model of Vitiligo

Mehdi Rashighi et al.

SCIENCE TRANSLATIONAL MEDICINE (2014)

Review Biotechnology & Applied Microbiology

Beyond annexin V: fluorescence response of cellular membranes to apoptosis

Alexander P. Demchenko

CYTOTECHNOLOGY (2013)

Article Dermatology

Autoimmune Destruction of Skin Melanocytes by Perilesional T Cells from Vitiligo Patients

Jasper G. van den Boorn et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)

Article Dermatology

Inflammatory changes in vitiligo - Stage I and II depigmentation

KE Sharquie et al.

AMERICAN JOURNAL OF DERMATOPATHOLOGY (2004)

Article Dermatology

Oxidative stress in malignant melanoma and non-melanoma skin cancer

CS Sander et al.

BRITISH JOURNAL OF DERMATOLOGY (2003)